Other headlines

Február 19, 2025
Az ASBIS továbbra is forgalmazza az új márkanév alatt elérhető Aurora Endpoint ...
Február 12, 2025
Az NVIDIA bemutatja az új GeForce RTX 50 grafikus kártyákat
Január 07, 2025
Az NVIDIA bemutatja az új GeForce RTX 50 grafikus kártyákat és laptopokat ...
December 13, 2024
Az Edgecore Networks, a nyílt hálózati megoldások globális vezetője, átfogó ...
December 06, 2024
A Prestigio Solutions, az ASBIS Group saját márkája, bővítette a távoli ...
December 05, 2024
Az Ubiqiuti bejelentette az Enterprise 7 WiFi Series Acces Point-okat: E7, E7 ...
December 04, 2024
Az AI forradalmasítja, hogyan dolgozunk, alkotunk és lépünk kapcsolatba ...
November 06, 2024
Mi a titka az infravörös melegítők iránti növekvő érdeklődésnek? ...
Október 28, 2024
Az ASBIS Group (WSE: ASB) - az ICT, IoT termékek, megoldások és szolgáltatások ...
Október 27, 2024
Számos fűtési rendszer hátrányai közé tartozik, hogy nem tud levegőt ...
ASBIS partners with IP Infusion in the EMEA region

Július 25, 2022

ASBIS, IP Infusion

ASBIS partners with IP Infusion in the EMEA region

ASBIS clients will now get access to IP Infusion’s leading networking software and solutions

In June 2022, value-added distributor ASBIS signed a distribution agreement with IP Infusion, further expanding its portfolio of networking solutions with industry-leading software products. The authorized area covers the EMEA region and includes all the 27 countries where ASBIS operates.

IP Infusion is a leading provider of open networking software and solutions for carriers, service providers, and data center operators. IP Infusion’s flagship OcNOS software is ranked as the industry’s Network Operating System (NOS) leader, enabling network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO).

Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier-grade robustness. IP Infusion’s software is market mature with over 500 customers and over 10,000 carrier-grade deployments for aggregation, disaggregated cell site gateways, provider edge routing, optical transport networks, data center networking and more.

“This is a great addition to our portfolio of networking solutions, and this agreement will help us bring even more value to our clients across many regions. ASBIS is happy to welcome IP Infusion as its partner and we are ready to do our best for a mutually successful future!” - commented Marek Horyl, Product Marketing Director at ASBIS.

“We are pleased to partner with ASBIS in the EMEA market to extend our reach in the EMEA regions through ASBIS’ distribution channel,” said Tom Savoie, Chief Sales Officer for IP Infusion. “Together IP Infusion and ASBIS offer powerful disaggregated software solutions for our customers to receive the promise and benefits of open networking.”

 

About ASBIS

ASBISC Enterprises PLC (WSE: ASB) is a leading Value Add Distributor, OEM, and Solutions Provider of IT, IoT, IoT, and AI across CEE, FSU, and MEA. The company specializes in value-added distribution (VAD), B2B market solutions and ICT products distribution from global suppliers. As IT industry leaders, the Group’s expert teams configure hardware products and software elements, cloud-based services, and technologies to create commercially viable solutions of choice. For more information, visit the company's website at www.asbis.com.

About IP Infusion

IP Infusion is a leading provider of open network software and solutions for carriers, service providers and data center operators. Our solutions enable network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier grade robustness. IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.

Nyilatkozat: Az oldalainkon közölt információk, közlemények a közzététel napján felelnek meg a valóságnak. A közétett információk, közlemények az oldalainkon folyamatosan elérhetőek maradnak, azonban a közzétételt követően nem tudjuk garantálni, hogy az esetlegesen bekövetkező változásoknak megfelelően frissítjük vagy töröljük a nem naprakész információkat. Ennek megfelelően semminemű felelősséget nem vállalunk azért, hogy a közzétételt követően az oldalainkon található információk pontosak maradnak.